KARYOPHARM THERAPEUTICS INC (KPTI)
US48576U1060 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 209.8M 94.08% | 157.1M -25.12% | 146.033M -7.04% | 155.78M 6.67% | 169.15M 8.58% | 206.12M 21.86% | 290.24M 40.81% | 369.66M 27.36% | 480.79M 30.06% | 582.97M 21.25% | 672.03M 15.28% | |
| EBITDA YoY % growth | -97.51M 42.95% | -141.58M -45.20% | -129.01M 8.88% | -163.2M -26.50% | -132.6M 18.75% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -98.3M 42.82% | -142.2M -44.66% | -129.54M 8.90% | -114.976M 11.24% | -97.129M 15.52% | -65.509M 32.55% | -60.792M 7.20% | 18.269M 130.05% | 107.42M 487.99% | 188.65M 75.62% | 270.24M 43.25% | |
| Operating Margin | -46.85% | -90.52% | -88.71% | -73.81% | -57.42% | -31.78% | -20.95% | 4.94% | 22.34% | 32.36% | 40.21% | |
| EPS YoY % growth | -1.71 37.36% | -2.03 -18.71% | -1.25 38.42% | -0.64 49.19% | -0.73 -14.25% | -0.46 36.51% | -0.24 47.97% | -0.07 70.21% | 0.22 414.29% | 0.49 120.45% | 0.51 3.09% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.25 30.06% | -0.20 36.25% | -0.16 -208.80% | -0.18 29.38% | -0.19 23.03% |
| Revenue Q2Q % growth | 38.791M 14.95% | 46.624M 40.75% | 50.49M 18.01% | 50.561M 30.37% | 51.275M 32.18% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -37.906M -0.26% | -19.685M 41.69% | -19.618M 30.24% | -23.718M 9.76% | -25.375M 33.06% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.26 13.33% | -0.27 | 0.01 | 3.03% |
| Q2 2024 Q2Q % growth | 0.15 151.72% | -0.30 | 0.45 | 149.25% |
| Q1 2024 Q2Q % growth | -0.32 -6.67% | -0.34 | 0.02 | 6.03% |
| Q4 2023 Q2Q % growth | -0.36 16.28% | -0.32 | -0.04 | -13.96% |
| Q3 2023 Q2Q % growth | -0.30 33.33% | -0.29 | -0.01 | -5.04% |
| Q2 2023 Q2Q % growth | -0.29 53.23% | -0.35 | 0.06 | 16.92% |
| Q1 2023 Q2Q % growth | -0.30 43.40% | -0.38 | 0.08 | 20.12% |
| Q4 2022 Q2Q % growth | -0.43 -193.48% | -0.36 | -0.07 | -19.42% |
| Q3 2022 Q2Q % growth | -0.45 34.78% | -0.58 | 0.13 | 21.99% |
| Q2 2022 Q2Q % growth | -0.62 12.68% | -0.65 | 0.03 | 4.02% |
| Q1 2022 Q2Q % growth | -0.53 31.17% | -0.64 | 0.11 | 17.65% |
| Q4 2021 Q2Q % growth | 0.46 177.97% | -0.53 | 0.99 | 187.47% |
| Q3 2021 Q2Q % growth | -0.69 5.48% | -0.69 | 0.00 | -0.47% |
| Q2 2021 Q2Q % growth | -0.71 -12.70% | -0.76 | 0.05 | 7.07% |
| Q1 2021 Q2Q % growth | -0.77 1.28% | -0.73 | -0.04 | -6.17% |
| Q4 2020 Q2Q % growth | -0.59 22.37% | -0.60 | 0.01 | 2.29% |
| Q3 2020 Q2Q % growth | -0.73 -8.96% | -0.74 | 0.01 | 1.01% |
| Q2 2020 Q2Q % growth | -0.63 11.27% | -0.59 | -0.04 | -6.31% |
| Q1 2020 Q2Q % growth | -0.78 28.44% | -0.71 | -0.07 | -10.23% |
| Q4 2019 Q2Q % growth | -0.76 20.83% | -0.68 | -0.08 | -11.21% |
| Q3 2019 Q2Q % growth | -0.67 15.19% | -0.84 | 0.17 | 20.50% |
| Q2 2019 Q2Q % growth | -0.71 -18.33% | -1.00 | 0.29 | 29.29% |
| Q1 2019 Q2Q % growth | -1.09 -39.74% | -0.89 | -0.20 | -22.69% |
| Q4 2018 Q2Q % growth | -0.96 | -0.87 | -0.09 | -10.86% |
| Q3 2018 Q2Q % growth | -0.79 | -0.91 | 0.12 | 13.27% |
| Q2 2018 Q2Q % growth | -0.60 | -0.82 | 0.22 | 27.02% |
| Q1 2018 Q2Q % growth | -0.78 | -0.63 | -0.15 | -22.98% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 38.783M 7.70% | 38.544M | 239K | 0.62% |
| Q2 2024 Q2Q % growth | 42.786M 13.86% | 36.903M | 5.883M | 15.94% |
| Q1 2024 Q2Q % growth | 33.126M -14.40% | 35.162M | -2.036M | -5.79% |
| Q4 2023 Q2Q % growth | 33.747M 0.44% | 36.113M | -2.366M | -6.55% |
| Q3 2023 Q2Q % growth | 36.009M -0.25% | 38.025M | -2.016M | -5.30% |
| Q2 2023 Q2Q % growth | 37.579M -5.34% | 36.736M | 843K | 2.29% |
| Q1 2023 Q2Q % growth | 38.698M -18.87% | 37.337M | 1.361M | 3.65% |
| Q4 2022 Q2Q % growth | 33.6M -73.40% | 35.821M | -2.221M | -6.20% |
| Q3 2022 Q2Q % growth | 36.1M -4.24% | 35.253M | 847K | 2.40% |
| Q2 2022 Q2Q % growth | 39.7M 75.66% | 36.303M | 3.397M | 9.36% |
| Q1 2022 Q2Q % growth | 47.7M 104.72% | 34.854M | 12.846M | 36.86% |
| Q4 2021 Q2Q % growth | 126.3M 259.83% | 40.868M | 85.432M | 209.04% |
| Q3 2021 Q2Q % growth | 37.7M 77.00% | 26.32M | 11.38M | 43.24% |
| Q2 2021 Q2Q % growth | 22.6M -32.54% | 26.153M | -3.553M | -13.59% |
| Q1 2021 Q2Q % growth | 23.3M 28.73% | 25.672M | -2.372M | -9.24% |
| Q4 2020 Q2Q % growth | 35.1M 93.92% | 29.961M | 5.139M | 17.15% |
| Q3 2020 Q2Q % growth | 21.3M 62.60% | 21.882M | -582K | -2.66% |
| Q2 2020 Q2Q % growth | 33.5M 252.63% | 27.97M | 5.53M | 19.77% |
| Q1 2020 Q2Q % growth | 18.1M 8,950.00% | 21.708M | -3.608M | -16.62% |
| Q4 2019 Q2Q % growth | 18.1M 8,950.00% | 16.667M | 1.433M | 8.60% |
| Q3 2019 Q2Q % growth | 13.1M 6,450.00% | 1.838M | 11.262M | 612.73% |
| Q2 2019 Q2Q % growth | 9.5M -52.26% | 96.104K | 9.404M | 9,785.08% |
| Q1 2019 Q2Q % growth | 200K -98.00% | 334.662K | -134.662K | -40.24% |
| Q4 2018 Q2Q % growth | 200K | 453.798K | -253.798K | -55.93% |
| Q3 2018 Q2Q % growth | 200K | 473.586K | -273.586K | -57.77% |
| Q2 2018 Q2Q % growth | 19.9M | 3.148M | 16.752M | 532.15% |
| Q1 2018 Q2Q % growth | 10M | 5.954M | 4.046M | 67.95% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 3.36% | 12.86% | 6.97% | 5.89% |
| Revenue | 0% | -0.3% | 0% | 0.24% |